Habitual nose-bleeding : a clinical study with special reference to occurrence, etiology and treatment by Beran, Martin, 1947-
©
Det här verket är upphovrättskyddat enligt Lagen (1960:729) om upphovsrätt till litterära och 
konstnärliga verk. Det har digitaliserats med stöd av Kap. 1, 16 § första stycket p 1, för forsk-
ningsändamål, och får inte spridas vidare till allmänheten utan upphovsrättsinehavarens 
medgivande. 
Alla tryckta texter är OCR-tolkade till maskinläsbar text. Det betyder att du kan söka och kopie-
ra texten från dokumentet. Vissa äldre dokument med dåligt tryck kan vara svåra att OCR-tolka 
korrekt vilket medför att den OCR-tolkade texten kan innehålla fel och därför bör man visuellt 
jämföra med verkets bilder för att avgöra vad som är riktigt.
This work is protected by Swedish Copyright Law (Lagen (1960:729) om upphovsrätt till litterära 
och konstnärliga verk). It has been digitized with support of Kap. 1, 16 § första stycket p 1, for 
scientific purpose, and may no be dissiminated to the public without consent of the copyright 
holder.  
All printed texts have been OCR-processed and converted to machine readable text. This means 
that you can search and copy text from the document. Some early printed books are hard to 
OCR-process correctly and the text may contain errors, so one should always visually compare it 
with the images to determine what is correct.
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20                                                
21
22
23
24
25
26
27
28
29
30
C
M
0
1
2
3
4
5
6
7
8
9
10
11
12
IN
C
H
HABITUAL NOSE-BLEEDING 
A clinical study with special reference to 
occurrence, etiology and treatment 
by 
Martin Beran 
Göteborg 1987 

HABITUAL NOSE-BLEEDING 
A clinical study with special reference to 
occurrence, etiology and treatment 
AKADEMISK AVHANDLING 
som för avläggande av medicine doktorsexamen vid Göteborgs Universitet 
kommer att offentligen försvaras i Sahlgrenska sjukhusets aula, fredagen 
den 13 februari 1987 kl. 09.00. 
av 
MARTIN BERAN 
leg. läk. 
Avhandlingen baseras på följande delarbeten: 
I. BeranM, PetrusonB. Occurrence of epistaxis in habitual 
nose-bleeders and analysis of some etiological factors. ORL. 
1986; 48:297-303. 
n. BeranM, PetrusonB. Changes in the nasal mucosa of habitual 
nose-bleeders. Acta Otolaryngol (Stockh). 1986; 102:308-314. 
HI. Johansson BR, BeranM, PetrusonB. Light and electron 
microscopy of varicose vessels and telangiomas in the nasal 
mucosa of habitual nose-bleeders. Acta Otolaryngol (Stockh). 
1985; 99:620-629. 
IV. BeranM, Stigendal L, Petrason B. Haemostatic disorders in 
habitual nose-bleeders. J Laryngol Otol. In press. 
V. Beran M, Petruson B. Transection of varicose vessels in the 
nasal mucosa of patients with recurrent epistaxis. A 2-year 
follow up. Clin Otolaryngol. 1986; 11:369-372. 
ABSTRACT 
HABITUAL NOSE-BLEEDING. A clinical study with special reference to occurrence, etiology 
and treatment. 
MARTIN BERAN, M.D., Departments of Otorhinolaryngology, Anatomy and Medicine II 
(Coagulation Laboratory) University of Göteborg, Göteborg, Sweden. 
Four per cent of the Swedish population are habitual nose-bleeders, i.e. suffer from nose-bleeds 
several times every year. The causes of these nose-bleeds are largely unknown. 
121 subjects with at least four nose-bleeds per year during the preceding two years have been 
studied. From the answers to a questionnaire, it was found that the bleedings had usually begun 
during childhood and mostly occurred spontaneously or after minor trauma to the nose. The 
nose-bleeds were sometimes associated with stress and common colds. Qose relatives with 
frequent nose-bleeds were more often reported among the habitual nose-bleeders than among the 
controls. 
The clinical examination revealed that all habitual nose-bleeders except one had local 
changes in the nasal mucosa. Abnormal vessels (varicose vessels, telangiomas and a network of 
small vessels) were found in 102 (84%) habitual nose-bleeders, which was a significantly higher 
prevalence than in the control group (33%). 
Morphologically, varicose vessels and telangiomas in the nasal mucosa were characterised by 
abnormally large, superficial vessels that bulged into the nasal lumen and were covered with a 
thin epithelium. The vessel wall consisted merely of a single layer of endothelial cells which in 
large areas appeared to be degenerated. However, there were also patches of active 
(proliferating) endothelial cells. The structure of the vessel wall indicates that these 
pathological vessels were the result of an endothelial growth process and not of dilatation or 
distension. No specific differences in the structure of the vessel wall could be detected between 
the varicose vessels and the telangiomas. 
Haemostatic disorders were found in 25 (27%) of the tested habitual nose-bleeders. In all cases 
except one, the defect was in the primary haemostasis. No correlation could be established 
between the occurrence of haemostatic disorders and abnormal vessels in the nasal mucosa. The 
bleedings did not seem to be more frequent or of longer duration in the patients with haemostatic 
disorders than among the other habitual nose-bleeders. 
Transection of varicose vessels in the nasal mucosa made the original vessels disappear and 
reduced the frequency of nose-bleeds. New varicose vessels were quickly formed but in spite of 
this there was a decrease in bleeding frequency during the two years of follow-up. 
It is concluded that recurrent nose-bleeds are most often caused by abnormal vessels in the nasal 
mucosa. These vessels are probably formed by endothelial proliferation. The propensity to 
develop abnormal vessels is presumably inherited. Haemostatic disorders were common in the 
study group but seemed to be of less importance in the explanation of the nose-bleeds than 
abnormal vessels. Therapy to reduce the frequency of nose-bleeds is avaiable. 
Key words: Epistaxis, recurrent, etiology, mucosal changes, vessels, microscopy, endothelial cell 
turnover, haemostasis, treatment. 
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ABSTRACT 
HABITUAL NOSE-BLEEDING. A clinical study with special reference to occurrence, etiology 
and treatment. 
MARTIN BERAN, M.D., Departments of Otorhinolaryngology, Anatomy and Medicine II 
(Coagulation Laboratory) University of Göteborg, Göteborg, Sweden. 
Four per cent of the Swedish population are habitual nose-bleeders, i.e. suffer from nose-bleeds 
several times every year. The causes of these nose-bleeds are largely unknown. 
121 subjects with at least four nose-bleeds per year during the preceding two years have been 
studied. From the answers to a questionnaire, it was found that the bleedings had usually begun 
during childhood and mostly occurred spontaneously or after minor trauma to the nose. The 
nose-bleeds were sometimes associated with stress and common colds. Close relatives with 
frequent nose-bleeds were more often reported among the habitual nose-bleeders than among the 
controls. 
The clinical examination revealed that all habitual nose-bleeders except one had local 
changes in the nasal mucosa. Abnormal vessels (varicose vessels, telangiomas and a network of 
small vessels) were found in 102 (84%) habitual nose-bleeders, which was a significantly higher 
prevalence than in the control group (33%). 
Morphologically, varicose vessels and telangiomas in the nasal mucosa were characterised by 
abnormally large, superficial vessels that bulged into the nasal lumen and were covered with a 
thin epithelium. The vessel wall consisted merely of a single layer of endothelial cells which in 
large areas appeared to be degenerated. However, there were also patches of active 
(proliferating) endothelial cells. The structure of the vessel wall indicates that these 
pathological vessels were the result of an endothelial growth process and not of dilatation or 
distension. No specific differences in the structure of the vessel wall could be detected between 
the varicose vessels and the telangiomas. 
Haemostatic disorders were found in 25 (27%) of the tested habitual nose-bleeders. In all cases 
except one, the defect was in the primary haemostasis. No correlation could be established 
between the occurrence of haemostatic disorders and abnormal vessels in the nasal mucosa. The 
bleedings did not seem to be more frequent or of longer duration in the patients with haemostatic 
disorders than among the other habitual nose-bleeders. 
Transection of varicose vessels in the nasal mucosa made the original vessels disappear and 
reduced the frequency of nose-bleeds. New varicose vessels were quickly formed but in spite of 
this there was a decrease in bleeding frequency during the two years of follow-up. 
It is concluded that recurrent nose-bleeds are most often caused by abnormal vessels in the nasal 
mucosa. These vessels are probably formed by endothelial proliferation. The propensity to 
develop abnormal vessels is presumably inherited. Haemostatic disorders were common in the 
study group but seemed to be of less importance in the explanation of the nose-bleeds than 
abnormal vessels. Therapy to reduce the frequency of nose-bleeds is avaiable. 
Key words: Epistaxis, recurrent, etiology, mucosal changes, vessels, microscopy, endothelial cell 
turnover, haemostasis, treatment. 
ISBN 91-7900-167-X. 37 pages. Correspondence to: Martin Beran, M.D., ENT Department, 
Uddevalla Hospital, S-451 80 Uddevalla, Sweden. 
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INTRODUCTION 
Nose-bleeding is a common symptom and 60% of a western population have 
had epistaxis at least once during their lives (Petruson 1974). Most of these 
people experience single nose-bleeds (occasional nose-bleeders) but four per 
cent of the population have several nose-bleeds every year (habitual nose-
bleeders). 
Many authors have studied patients with occasional and/or severe bleedings 
from the nose ( Hallberg 1952, Har a 1962, Saunders 1968, Juselius 1974, 
Petruson 1974, Harrison 1982). On the other hand, studies of patients with 
repeated, small bleedings are few. 
In this investigation, habitual nose-bleeders have been studied with the aim 
of elucidating the etiology and clinical features. 
The blood vessels in the nasal mucosa 
The upper parts of the nose are supplied with blood from the internal carotid 
artery via the anterior and posterior ethmoidal arteries. The external carotid 
artery supplies the lower and the anterior parts of the nose via the spheno­
palatine, the facial and the greater palatine arteries. These vascular systems are 
connected with anastomoses (Shaheen 1970). Terminal branches of the vessels 
anastomose in the anterior part of the septum, the Locus Kiesselbachi (Cauna 
1982). 
The vessels in the nasal mucosa are located in the lamina propria (fig 1). The 
subepithelial layer contains continuous and fenestrated capillaries and arterio­
venous anastomoses, embedded in a connective tissue rich in cells and fibrils. 
In the middle, glandular layer, the capillaries surround the glands. The large 
blood vessels and sinusoids are located in the deepest, basal layer (Mygind 
1979). 
The endothelial cells of the subepithelial capillaries may be extremely 
attenuated. The endothelium is surrounded by scattered pericytes with ability 
of contraction. The wall of the large vessels (arterioles and venules) and the 
sinusoids consists of a continuous layer of non-fenestrated endothelial cells 
and a layer of smooth muscle cells (Cauna and Hinderer 1969). 
Fig 1. Light micrograph of normal nasal mucosa from the anterior edge of the lower turbinate. 
Epithelium(E); Subepithelial capillaries, 0 5-10pm (arrowhead); Glands (arrow); 
Sinusoids (asterisks). 
Normal haemostasis 
The mechanism of haemostasis consists of four components: vessel wall 
reaction, platelet activation and aggregation, coagulation and fibrinolysis. 
After injury to a blood vessel, it contracts and platelets adhere to denuded 
collagen fibres. The adhesion releases platelet factors which increase platelet 
aggregation, leading to development of a platelet plug, 'primary haemostasis' 
(Vermylen et al.1983). Between the aggregated platelets, a blood clot is formed 
by the extrinsic and intrinsic systems of coagulation (Lämmle and Griffin 
1985). In the final step of haemostasis, the blood clot is dissolved by fibrinolysis 
(Erickson et al. 1985). 
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Etiology of recurrent nose-bleeds 
Various diseases and disorders of the nasal mucosa and the haemostasis are 
known to have recurrent epistaxis as a symptom. The following etiological 
groups can be identified: defects in the nasal mucosa, tumours in the nose, 
abnormal vessels in the nasal mucosa and impaired haemostasis. 
Defects in the nasal mucosa 
Rhinitis anterior sicca and chronic septal ulcer are conditions described to give 
repeated small bleedings from the nose. In atrophic areas, crusting is frequent 
and bleedings are considered to occur when these crusts are removed 
(Saunders 1980). More pronounced atrophy of the septal mucosa may denude 
the cartilage, resulting in a septal perforation (Manz 1977), from the margin of 
which recurrent bleedings are common (Johnson 1968, Fairbanks 1980). 
Tumours in the nose 
Granuloma pyogenicum and haemangioma in the nose are lesions giving 
recurrent epistaxis as one of the main symptoms (Ash and Old 1950, Wenig et 
al. 1985). Nose-bleeding, often repeated, is the most common symptom in 
patients with nasopharyngeal angiofibroma (Witt et al. 1983). 
Patients with inverted papilloma or malignant tumours in the nose may 
have recurrent small nose-bleeds, but in most cases other symptoms such as 
purulent secretion and obstruction are more prominent (Lawson et al. 1983, 
Vimpel et al. 1985). 
Abnormal vessels in the nasal mucosa 
Varicose vessels in the nasal mucosa are often seen in subjects with recurrent 
nose-bleeds (Shaheen 1979) but they may also be present in subjects without 
bleedings (Dohlman 1938). 
Hereditary haemorrhagic telangiectasia (Mb Osier) has recurrent nose- bleeds 
together with telangiectatic lesions and inheritance as its main diagnostic 
criteria (Osier 1901). Morphological studies of the telangiectatic lesions have 
shown wide vessels with defective vessel walls (Jahnke 1970). 
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Impaired haemostasis 
Frequent epistaxis is a common symptom in patients with 'minor bleeding 
disorders' (Bachmann 1980). Children with recurrent epistaxis as the sole 
symptom often have impaired haemostasis (Kiley et al. 1982). 
Disorders in the primary haemostasis, such as decreased platelet count or 
platelet dysfunction, mainly result in bruises and mucosal bleedings (Cronberg 
1968). Acetylsalicylic acid blocks the prostaglandin synthesis, which results in 
an impaired platelet function (Nieuwenhuis and Sixma 1983), and intake of 
acetylsalicylic acid has been related to nose-bleeds (Petruson 1974). 
Nose-bleeds are often seen in blood malignancies, when the platelet count 
decreases. In Waldenstrom's macroglobulinemia, the macroglobulin interferes 
with the platelet function and nose-bleeds are considered an early symptom 
(MacKenzie and Fudenberg 1972, Wells et al. 1977). 
In von Willebrand's disease bleeding from mucous membranes is common 
and recurrent nose-bleeds occur in more than half of the patients (Silver 1973). 
The haemostatic disorder is inherited and characterised by a prolonged 
bleeding time, a defect or decreased level of von Willebrand factor and, in 
many cases, also a decreased level of factor VIII (Zimmerman and Ruggeri 
1983). 
Defects in the coagulation are more seldom associated with repeated 
nose-bleeds. Symptoms in patients with haemophilia A and B have been 
studied and nose-bleeding was only reported as an occasional symptom. 
(Ramgren 1962). Haemophilia C (factor XI deficiency) often appears without 
spontaneous bleedings (Edson et al. 1967). Isolated defects of coagulation factor 
V, VII or X are rare conditions in which nose-bleeds have been decribed as a 
symptom (Marder and Shulman 1964, Girolami et al. 1970, Seeler 1972). 
Treatment with oral anticoagulants reduces the levels of coagulation factors II, 
VII, IX and X and occasional epistaxis has been reported as a complication of 
the treatment in about 5% of the patients (Svensson et al. 1985). 
Increased fibrinolytic activity in blood and nasal mucosa during nose-
bleeding has been demonstrated and suggested to be of importance in the 
occurrence of repeated nose-bleeds (Petruson 1974). Kwaan and Silverman 
(1973) reported an increased fibrinolytic activity in telangiectasias in patients 
with Mb Osier. 
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Treatment of recurrent nose-bleeds 
Nose-bleeds from septal perforations have been shown to decrease after 
obturation with a septal button (van Dishoeck and Lashley 1975, Kern et al. 
1977) or successful operative closure of the perforation (Fairbanks 1980). 
Haemangiomas, granulomas or telangiectatic polyps with recurrent nose­
bleeds are recommended to be extirpated, together with the underlying 
perichondrium (Ash and Old 1950, Vaheri 1958, Wenig et al. 1985). 
In patients with varicose vessels in the nasal mucosa, cauterisation or 
electrocoagulation of the vessels is recommended (Shaheen 1979). Transection 
of the varicose vessel has been shown to reduce the frequency of nose-bleeds 
(Pinsker and Holdcraft 1971). A limited septal dermoplasty has been performed 
in patients with troublesome bleedings from a 'fragile septal mucosa' or 
superficially lying septal vessels with, a long-lasting decrease of the nose-bleeds 
(Letson and Birck 1973, Beck 1978). 
In patients with Mb Osier, septal dermoplasty according to Saunders (1960) 
has been shown to reduce the frequency of nose-bleeds. (Saunders 1968, 
McCaffrey et al. 1977, Uls0 et al. 1983). 
Systemic treatment with estrogen has been reported to reduce the nose-bleeds 
in patients with Mb Osier but complications from the cardiovascular system 
may be severe (McCaffrey et al. 1977, Harrison 1982). 
Treatment with an antifibrinolytic drug (transexamic acid, Cyklokapron®) 
has reduced the frequency of bleedings in several patients with Mb Osier 
(Petruson, personal communication). 
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DEFINITIONS 
Habitual nose-bleeding: Bleeding from the nose four times or more yearly 
during the last two years. 
Mucosal atrophy: Either of the two mucosal changes defined below. 
Rhinitis anterior sicca: A clearly visible pale-white and dry area in the 
anterior part of the septal mucosa and signs of mucosal dysfunction with 
crusting. 
Septal perforation: A visible hole in the nasal septum. 
Abnormal vessels: Any of the four categories of vascular changes defined 
below, seen on clinical examination after topical decongestion of the nasal 
mucosa. 
Varicose vessel(s): A clearly visible vessel of varying thickness and length, 
usually lying superficially in the septal mucosa, (see Fig.2, paper H) 
Network of small vessels: Very thin visible vessels arranged in a network 
covering a large part of the anterior nasal mucosa. 
Single telangioma: A small circumscript, tumorous lesion of vessels with a 
more or less rough surface, slightly elevated and located mostly on the nasal 
septum. 
Multiple telangiomas: More than three telangiomas in the nasal mucosa, 
(see Fig. 3, paper H) 
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AIMS OF THE STUDY 
The general aim of this investigation was to elucidate the problems connected 
with habitual nose-bleeders. 
The specific aims of the studies were: 
- to explore the epidemiology and to establish which diseases or conditions 
might be associated with recurrent nose-bleeds (I), 
- to determine the prevalence of macroscopical changes in the nasal mucosa 
(H), 
- to describe the structure of abnormal blood vessels in the nasal mucosa (HI), 
- to investigate the prevalence of different bleeding disorders (IV) and 
- to evaluate the direct and long-term effects of transection of varicose vessels 
in the nasal mucosa.(V) 
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STUDY GROUPS 
Papers I and II 
The study group of these papers comprised 121 subjects with bleeding from the 
nose four times or more yearly during the preceding two years. The subjects 
were recruited by means of a medical article in the local newspaper and were 
asked to contact the clinic. All who replied were sent a questionnaire (see 
appendix). Those who answered the questionnaire, fulfilled the definition of 
habitual nose-bleeding and came to an examination at the outpatient clinic 
were included in the study. 
The mean age of the study group was 40 years (range 8-76). Seventy-four (61 %) 
were male and 47 (39%) were female (Fig.2). 
Number of 
habitual 
bleeders 
I I Males (74) 
Females (47) 
30 
20 
10 
< 19 20-39 40-59 > 60 Years 
of age 
Hg. 2. Distribution of the habitual nose-bleeders 
according to age and sex (n=121). 
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Paper III 
Specimens for microscopy of the telangiomas in the nasal mucosa were 
obtained from 22 habitual nose-bleeders. Biopsy specimens of varicose vessels 
were taken from 20 patients during transection according to Pinsker and 
Holdcraft (1971). In 23 habitual nose-bleeders, both with and without abnormal 
vessels in their nasal mucosa, biopsy specimens of macroscopically normal 
mucosa were taken from the anterior-inferior edge of the inferior turbinate. 
Paper IV 
The 121 habitual nose-bleeders in study group (I and 33) were invited to 
participate in a screening examination for bleeding disorders. Ninety-one 
subjects accepted and were included in the study group of this paper. 
Fifty-three (58%) were male and 38 (42%) were female. Their mean age was 42 
years (range 10-73). 
Paper V 
Twenty-two habitual nose-bleeders with varicose vessels in the nasal mucosa 
as the only registered abnormality were operated on with transection of the 
varicose vessels according to the method described by Pinsker and Holdcraft 
(1971). Their mean age was 22 years (range 11-52). Thirteen were male and 9 
were female. Sixteen of these patients were from the original study group 
(I and H) and six more entered the study from the outpatient clinic. 
CONTROL AND REFERENCE GROUPS 
A control group consisting of 121 in-patients were chosen consecutively and 
matched with the study group for age and sex at the ENT Department, 
Uddevalla Hospital, Sweden. Patients with all kinds of ENT-diseases were 
included, except those hospitalised owing to nose-bleeding and those who 
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were habitual nose-bleeders. 
As reference groups for the blood-pressure measurements, a Bergen 
population sample (Bae et al. 1957) and a sample of Swedish schoolchildren 
(Lindberg and Sigström 1980) were used. 
METHODS 
Questionnaires (I) 
The questionnaire for the habitual nose-bleeders comprised 77 no/yes 
questions. The patients in the control group answered seven of these questions 
in a separate questionnaire (see appendix). 
Clinical examination (I and II) 
The subjects in the study groups and the control group underwent an ENT-
examination by the author. Observations from the examination were recorded 
on a special form. The nasal mucosa was examined before and after 
decongestion. Photos were taken of changes in the nasal mucosa through a 
fibre-endoscope (Storz-Hopkins Optik, 0 4 mm, 1215 A, Storz Lichteinheit 558 
B, Olympus OM 1, Kodacolor 400 ASA). 
The blood pressure was measured in the seated position after 5 minutes rest. 
Blood samples were taken for routine tests. 
Microscopical examination (III) 
The specimens were fixed by immersion in a 2% paraformaldehyde + 2.5% 
glutaraldehyde mixture in 0.05 M cacodylate buffer. After treatment with 
osmium tetroxide, they were dehydrated, embedded in Epon and sectioned on 
Reichert ultramicrotomes. Semithin sections (0,5-ljxm) were cut for 
examination under a Leitz Dialux EB 20 light microscope. Ultrathin sections 
(~70 rim) were examined in Philips 300 and 400 electron microscopes. 
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Haemostatic examination (IV) 
Screening for haemostatic disorders was performed at the Coagulation 
Laboratory, Sahlgrenska Hospital, Göteborg, Sweden. The 91 investigated 
subjects were asked to refrain from taking acetylsalicylic acid for ten days before 
the examination. 
The following screening tests were performed: platelet count, bleeding time 
according to Ivy, activated partial thromboplastin time (APTT), factor n-VH-X 
(prothrombin time), fibrinogen, thrombin time, FDP (fibrin(ogen)-
degradation products), factor VIII:C and capillary fragility. 
Patients with abnormal test results at the screening examination were 
re-examined and when still abnormal results, extended examination with the 
aim of diagnosing any haemostatic disorders were performed. 
Method of operation and follow-up (V) 
The transection of varicose vessels was performed at the outpatient clinic. 
Topical anaesthesia was used and the varicose vessels were transected 
horizontally with a pointed scalpel through the mucosa and the peri­
chondrium (Fig.3). An anterior gauze tampon soaked in ointment was used to 
Fig3. Position of the horizontal transections 
in a varicose vessel. 
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stop the bleeding and was left in place for 48 hours. The extension of the 
varicose vessels was recorded on special record forms pre- and post­
operatively after 1-2 months, 6-9 months, 12-14 months and 24-26 months. 
Statistics 
The information from the questionnaires and the examination record forms 
from both the habitual nose-bleeders and the matched controls were 
computed. When the habitual nose-bleeders were compared with the control 
group, Pitman's permutation test (Bradley 1968) was applied to the matched 
groups and the results adjusted according to Mantel 1963 ( I and H). 
The mean values of the blood pressures of the different age-groups in the 
population samples used as reference groups (B0e et al. 1957, Lindberg and 
Sigström 1980) were connected by lines. The blood pressures of the habitual 
nose-bleeders were plotted and compared with these mean value lines. The 
Sign test was used to test whether there was any difference in blood pressure 
between the population samples and the habitual nose-bleeders (I). 
RESULTS AND CONCLUSIONS 
Occurrence of nose-bleeds (I) 
The nose-bleeds started during childhood in more than half of the habitual 
nose-bleeders and most of them stated that they had bled repeatedly for the last 
ten years. More than two-thirds of the subjects had bled at least once a month 
during the preceding two years. The bleedings were usually of short duration 
and ceased within ten minutes. Seven out of ten had consulted a doctor due to 
nose-bleeding and one tenth of these had been hospitalised. 
Most bleedings started spontaneously but minor trauma to the nose, like 
picking or blowing the nose, also initiated nose-bleeds. More than half of the 
nose-bleeders answered that the bleedings were connected with stress and/or 
tiredness and common colds. 
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Conclusions 
Most of the habitual nose-bleeders had suffered from recurrent bleeding for 
many years. The bleedings mostly started without any obvious reason and at 
other times in connection with minor trauma to the nose, a common cold or a 
stress situation. 
Diseases, routine blood tests and blood pressure in the study group (I) 
More than seven out of ten bleeders were healthy, without any disease known 
to them. Some cardiovascular disorders were reported among the bleeders 
over 40 years of age as might be expected in this age-group. 
Anaemia was observed in fifteen habitual nose-bleeders. Two of them, who 
said that they bled from the nose every day, had a haemoglobin concentration 
below 100 g/1. An increased ESR were found in ten of the nose-bleeders. Only 
one, a pregnant woman, had an ESR above 50 mm/h. Most of the other results 
of the routine blood tests were within the reference values of the hospital. 
No significant difference was found when the blood pressures of the habitual 
nose-bleeders were compared with the mean blood pressures of the reference 
groups. 
Conclusions 
Most of the habitual bleeders had no systemic disease of which the nose-bleeds 
could be regarded as a symptom. In some nose-bleeders, the loss of blood 
resulted in anaemia. 
Mucosal atrophy and abnormal vessels in the nasal mucosa (II) 
All habitual nose-bleeders except one had nasal mucosal changes. One third 
had more than one registered change. The prevalence of both mucosal atrophy 
and abnormal vessels was significanly higher among the habitual nose-
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bleeders than among the controls. Mucosal atrophy without concomitant 
presence of abnormal vessels was, however, equally common in both groups. 
Abnormal vessels (varicose vessels, telangioma or a network of small vessels) 
were found in 102 (84%) nose-bleeders. Varicose vessels were the most 
frequent abnormality but were also seen in the control group. Telangioma and 
a network of small vessels were only seen among the habitual nose-bleeders. 
Conclusion 
Abnormal vessels, observed in more than eight out of ten habitual nose-
bleeders, probably explain most of the recurrent bleedings. 
Morphology of varicose vessels, telangiomas and macroscopically normal 
mucosa (III) 
The abnormal vessels bulged into the nasal lumen and were covered with 
sparse connective tissue and a rather thin epithelium. The varicose vessels 
were isolated very wide vascular channels and the telangioma consisted of 
multiple closely apposed wide vessels. The diameter of these vessels were up 
to one hundred times larger than normal subepithelial capillaries. However, 
no specific morphological feature of the vessel wall structure that 
distinguished the two lesions could be discerned. 
The vessel wall lacked smooth muscle cells and pericytes forming an 
organised media as would be expected in normal vessels of comparable size. 
The endothelium consisted of a single layer of mostly thin and seemingly 
degenerating cells that at some points even failed to form a continuous tunic. 
At other spots, organelle-rich endothelial cells could be seen as well as 
endothelial cells of 'normal' appearance. Particularly in telangiomas, 
multiple-layered periendothelial basal lamina was observed, indicating an 
increased vascular wall turnover. 
The biopsies from the inferior turbinate had an intact mucosal lining with 
apparently normal mucosal vessels. 
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Conclusions 
The abnormal vessels were wide, with a superficial position in the nasal 
mucosa. They were thin-walled, with mostly degenerating endothelium, and 
lacked elements for contraction. It is obvious that they might easily rupture 
and bleed. The presence of scattered, active, organelle-rich endothelial cells 
suggests that these vessels are formed by cell multiplication, not by distension 
or dilatation of a normal vessel. 
Heredity (I and II) 
The habitual nose-bleeders stated that their close relatives (parents, brothers 
and sisters) had recurrent nose-bleeds significantly more often than did the 
controls. 
Close relatives of the bleeders with varicose vessels in the nasal mucosa as 
the sole local change had recurrent nose-bleeds significantly more often than 
relatives of the patients from the control group without varicose vessels. 
Conclusion 
The propensity to have recurrent nose-bleeds is presumably inherited. 
Haemostatic disorders (IV) 
Eleven of the 91 tested nose-bleeders had increased capillary fragility as the 
only abnormality. Fourteen (17%) were found to have a haemostatic defect, all 
except one in the primary haemostasis. Four of these had a mild form of von 
Willebrand's disease. 
No connection could be established between the haemostatic disorders and 
the presence of abnormal vessels in the nasal mucosa. Only a tendency to 
increased bleeding frequency and longer duration of the bleedings could be 
observed in the nose-bleeders with haemostatic disorders. 
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Conclusions 
Every fourth habitual nose-bleeder had a haemostatic disorder. The occurrence 
of abnormal vessels in the nasal mucosa could not be correlated to the 
haemostatic disorders. Although plausible, it could not be proven that 
impaired haemostasis gave longer or more frequent bleedings. 
Treatment of varicose vessels by transection (V) 
After transection, the decrease in frequency of nose-bleeds was significant 
during both years of follow-up. Slight mucosal atrophy at the transection site 
was observed on one-third of the operated sides. 
The original varicose vessel could not be seen at the first postoperative 
control. However, new varicose vessels were formed at new sites and after two 
years almost all patients had new varicose vessels. 
Conclusions 
The transection made the original varicose vessels disappear and markedly 
reduced the frequency of nose-bleeds. In spite of the rapid formation of new 
vessels, the frequency of nose-bleeds remained low during the two years of 
follow-up. 
GENERAL DISCUSSION 
Many people have experienced nose-bleeding. Most of them have had single 
nose-bleeds but four per cent suffer from repeated bleedings (Petruson 1974). 
Several studies have been performed on patients with occasional or severe 
bleedings from the nose but little attention has been paid to nose-bleeders 
suffering from recurrent small bleedings. It was therefore decided to study 
subjects with habitual nose-bleeding and invite them to participate in this 
investigation by means of an article in the local newspaper. 
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From the findings in this investigation the typical history of a habitual 
nose-bleeder can be summarised as follows: 
A middle-aged, subjectively healthy, person of either sex who has experienced 
repeated nose-bleeds since childhood and for the last two years has had 
bleedings from the nose at least once a month. The bleedings are generally of 
short duration. They often occur spontaneously and sometimes in connection 
with a stress situation. Blowing or picking the nose may easily result in a 
bleeding. Many close relatives also suffer from repeated nose-bleeds. The 
patient has not observed any other bleeding tendency. 
Atrophy of the nasal mucosa has been related to recurrent nose-bleeds (Manz 
1977, Saunders 1980, Fairbanks 1980). In this study, mucosal atrophy, as the 
only observed defect in the nasal mucosa, was observed inl5 per cent of the 
habitual nose-bleeders and was as common in the control group. The bleedings 
in the nose-bleeders may possibly be explained by a more pronounced mucosal 
atrophy but the possibility of an undiscovered abnormal vessel in the nasal 
mucosa cannot be excluded. 
Coincident presence of mucosal atrophy and abnormal vessels in the nasal 
mucosa was more common in the habitual nose-bleeders than in the controls. 
It is known that mucosal atrophy develops over a long period of time when 
the nasal mucosa is exposed to irritants (Hussarek 1968) and it therefore seems 
probable that the mucosal atrophy in the nose-bleeders with abnormal vessels 
develops as a consequence of repeated trauma to the nose e.g. from the efforts 
to stop the bleedings. 
Varicose vessels in the nasal mucosa were the most commonly recorded 
change in the habitual nose-bleeders. These vessels have earlier been described 
in connection with repeated nose-bleeds (Pinsker and Holder aft 1971, Shaheen 
1979) but may also occur in the nasal mucosa without nose-bleeding (Dohlman 
1938). One-third of our control patients had varicose vessels in the nasal 
mucosa without habitual nose-bleeding. After transection, the new varicose 
vessels that were formed had a low tendency to bleed. 
The tendency of some varicose vessels to bleed might depend on a larger 
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diameter, thinner walls, greater extension or more superficial position in the 
nasal mucosa. 
In patients with Mb Osier, repeated nose-bleeds are known to come from the 
telangiectasias in the nasal mucosa (Saunders 1980, Harrison 1982). Seven of 
the habitual nose-bleeders had Mb Osier and more than one-fourth of the 
nose-bleeders had single telangiomas in the nasal mucosa, while no such 
changes were present in the controls. This shows that even the presence of 
single telangiomas is correlated to repeated nose-bleeds. 
The morphological examination of the varicose vessels and telangiomas 
showed that the diameter of the vessels was up to one hundred times larger 
than normal subepithelial capillaries. The vessels had a superficial position in 
the nasal mucosa, being covered by only a sparse layer of connective tissue and 
a thin epithelium. The vessel wall was delicate, with most areas lined by very 
or extremely thin endothelial cells. Periendothelial cells with contraction 
ability, i.e. pericytes and smooth muscle cells, were almost completely absent. 
It seems reasonable to assume that a vessel with such a structure, situated in a 
mucosa often subjected to trauma, may rupture easily and cause a nose-bleed. 
The distending force in the vascular wall is proportional to the diameter times 
the pressure (Laplace's law), which means that in these huge vessels even 
moderate pressure will give a considerable distending force on the weak vessel 
wall. 
Once a bleeding from these vessels has started, the clotting mechanisms alone 
will be responsible for the control of haemorrage since local vessel contraction 
cannot be elicited in the absence of smooth muscle cells in the vessel wall. 
Furthermore, the ability to form a platelet plug is probably also impaired as the 
platelets will meet no or very little collagen, which is necessary for platelet 
adhesion (Santoro and Cunningham 1981), due to the sparse layer of 
connective tissue between the vessel wall and the epithelium. 
Disorders of especially the primary haemostasis are known to cause nose­
bleeds (Cronberg 1968, Silver 1973, Bachmann 1980, Kiley et al 1982). The 
disorders in the habitual nose-bleeders were all in the primary haemostasis 
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except one, and the prevalence of such disorders was more than a hundred 
times higher than estimated in a normal population (Bachmannl980). One 
would expect that habitual nose-bleeders with haemostatic disorders would 
have more frequent and severe bleedings than the other nose-bleeders but 
such a connection could not be proven. Nor were there any connections 
between haemostatic disorders and the presence of abnormal vessels in the 
nasal mucosa. It is therefore probable that the reduced capacity of local 
haemostasis as indicated above plays a more important role in recurrent 
nose-bleeds than minor general haemostatic disorders. 
However, since so many haemostatic disorders were found, some of them of 
clinical importance, it seems reasonable to offer habitual nose-bleeders a 
limited investigation of the haemostasis, with determination of the bleeding 
time according to Ivy, platelet count, APTT and prothrombin time. 
Telangiomas collected from patients with Mb Osier had the same morphology 
as the lesions from patients with single telangiomas. Although the telangioma 
and varicose vessel had a different gross organisation in the nasal mucosa, the 
structure of the vessel wall was similar. It was also found that 13 habitual 
nose-bleeders had telangiomas in the nasal mucosa together with varicose 
vessels. Close relatives to the habitual nose-bleeders with abnormal vessels in 
the nasal mucosa often had repeated nose-bleeds but whether these bleedings 
were caused by abnormal vessels in the nose is unknown. These observations 
suggest that the familial tendency to have repeated nose-bleeds might be 
coupled to a hereditary disposition to form abnormal vessels. 
As previously mentioned, large areas of the endothelium in telangiomas and 
varicose vessels appeared to be degenerating, whereas regional accumulations 
of 'active' endothelial cells were seen. These observations indicate that the 
vessels obtain their dimensions by proliferation of endothelial cells and not by 
passive dilatation. The rapid formation of new varicose vessels after 
transection also indicates that the vessels are created by an active process. 
An interesting biological question is which angiogenetic factor(s) governs the 
formation of abnormal vessels in the nasal mucosa. Angiogenetic substances, 
which have been isolated from tumours and normal tissues, can give a signal 
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to endothelial cells to generate new capillaries. However, in normal tissue, 
anti-angiogenetic substances control and regulate the formation of new 
capillary vessels. The turnover of endothelial cells is in most tissues measured 
in years. It has been suggested that alterations in the equilibrium between 
angiogenetic and anti-angiogenetic factors may induce growth or regression of 
microvessels (Folkman 1986, Schor and Schor 1983). 
It is well known that angiogenesis is induced by a proceeding inflammation 
and several angiogenetic substances have been demonstrated in inflammatory 
cells (Schor and Schor 1983). Dicumylperoxide produced an inflammatory 
reaction in the nasal mucosa of rabbits and superficial vessels were quickly 
formed as reported by Hansson and Petruson (1986). Furthermore, workers 
exposed to dicumylperoxide more often had visible vessels in the nasal 
mucosa than subjects working at a hospital (Petruson and Järvholm 1983). 
However, the habitual nose-bleeders in this study were not exposed to any 
known specific factor in the environment causing inflammation. Nor had 
they had more common colds or were more allergic than could be expected. It 
therefore seems probable that constitutional factors govern the formation of 
abnormal vessels in the habitual nose-bleeders. 
Treatment of patients with habitual nose-bleeding includes giving them 
information on the etiology and how to handle their nose in order to avoid 
bleedings. 
In the habitual nose-bleeders with mucosal atrophy and crusting, cleaning the 
nose with a salt solution and moistening the atrophic area with oil or oinment 
was recommended and seemed to be of value. 
Bleedings from the margin of a septal perforation may diminish after 
obturation of the perforation with a septal button (van Dishoeck and Lashley 
1975, Kern et al. 1977) or disappear after successful operative closure (Fairbanks 
1980). 
Varicose vessels of small extension can be cauterised, e.g. with chromic acid. 
When the varicose vessels are more extended, transection of the vessels is a 
simple and efficient method of reducing the frequency of nose-bleeds. In some 
patients, the result of transection may be insufficient and a circumscribed 
dermoplasty may be considered (Letson and Birck 1973, Beck 1978). 
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Single lesions, such as telangiomas or haemangiomas, in the nasal mucosa 
are suitable for surgical extirpation, including the underlying perichondrium 
(Wenig et al. 1985), as were done in the habitual nose-bleeders with single 
telangiomas in this study. 
There is an increased fibrinolytic activity in telangiomas from patients with 
Mb Osier (Kwaan and Silverman 1973) and systemic treatment with an 
antifibrinolytic drug (tranexamic acid, Cyklokapron®) has been found to 
reduce the frequency of nose-bleeds (Petruson 1986, personal communication). 
Septal dermoplasty is a good method of reducing the bleedings in patients 
with Mb Osier (Saunders 1968, McCaffrey et al. 1977, Ulso et al. 1983) and was 
performed in two of the habitual nose-bleeders with this disease. 
Systemic treatment with estrogen decreases the bleedings from the nose but is 
associated with various complications and should therefore be used with 
discretion and only when other treatments have failed (McCaffrey et al. 1977, 
Harrison 1982). 
Visible vessels in patients with recurrent nose-bleeds and telangiectasias in 
patients with Mb Osier have been treated with the Argon-Laser technique 
(Lenz and Eichler 1984). However, it is too early to evaluate this therapy as the 
effects on the nasal mucosa, the septal cartilage and formation of new vessels 
are largely unknown. 
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APPENDIX 
The questions with figures in bold print were included in the shorter questionnaire for 
control subjects. 
QUESTIONNAIRE FOR SUBJECTS WITH RECURRENT NOSE-BLEEDS 
Name.. Address  
Telephone Date of birth 
Date, when answering the questions  
1. AGE. How old are you? 
2. SEX. 
NUMBER OF NOSE-BLEEDS 
3. How long have you had nose-bleeds several times every year? 
4. Have you had recurrent nose-bleeds every year 
5. How many nose-bleeds have you had during the last 
two years? 
6. Do you generally have nose-bleeds at least 
NOSE-BLEEDS LAST WEEK 
7. Have you had a nose-bleed during the last 7 days? 
8. Have you had a common cold during the last 7 days? 
9. Have you taken any drug for pains containing acetylsalicylic 
acid (e.g. Albyl, Aspirin, Bamyl, Doleron, Dispril, Magnecyl, 
Spalt, Treo) during the last 7 days ? 
years of age 
• male • female 
• last 2 years 
• last 10 years 
• more than 10 years 
• since childhood? 
• since teenage? 
• only as an adult? 
• less than once/year 
• 1-3 times/year 
• 4-6 times/year 
• 6-12 times/year 
Q more than 12 
times/year 
• once a month 
Q once a week 
• once a day 
• no Q yes 
• no • yes 
• no • yes 
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DURATION OF THE NOSE-BLEEDS 
10. How long do you generally bleed from the nose at 
each bleeding episode? 
11. Once a bleeding has started, during what time do new bleedings 
occur after the first bleeding has ceased? 
12. How long do you generally have to stay at home or rest at work 
when you have nose-bleeds? 
13. Do you sometimes have to stay at home for days due to 
nose-bleeds? 
14. How many days per year must you stay at home 
due to nose-bleeds? 
TREATMENT FOR NOSE-BLEEDS 
15. Have you consulted a doctor due to nose-bleeding? 
16. How many times have you consulted a doctor due to nose-bleeding 
during the last two years? 
17. Have you ever been admitted to hospital due to nose-bleeding? 
18. How many times have you been admitted to hospital during 
the last two years? 
REASONS FOR THE NOSE-BLEEDS 
19. Do you often bleed from the nose in connection with colds? 
20. Do you often bleed from the nose when you have taken medicine 
containing acetylsalicylic acid?(see question 9) 
21. Do you often bleed from the nose in connection with stress 
and/or tiredness? 
• less than 5 min. 
• 5-10 min. 
• 10-30 min. 
• 30-60 min. 
• more than 1 hour 
• 1 day 
• 2-4 days 
• 5-7 days 
• more than 7 days 
• need no rest 
• less than 1 hour 
• 1-4 hours 
• 5-8 hours 
Q no 
• yes, 1 day 
• yes, 3-4 days 
• yes, 5-7 days 
• yes, more than 
7 days 
days 
Q no 
• yes, times 
times 
• no 
• yes, times 
times 
• no • yes 
Q have not noticed any 
connection 
• have noticed a 
connection 
• no • yes 
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22. Do you often bleed from the nose in connection with physical 
strain, e.g. heavy lifts or sports? • no • yes 
23. Do you often bleed from the nose during menstruation? • no • yes 
24. Have you noticed any other connection with the nose-bleeds? What connection?  
25. Do you often bleed after picking your nose? • no • yes 
26. Do you often bleed after blowing your nose? • no • yes 
27. Do you often bleed without any obvious reason? • no Q yes 
28. Do you often bleed at a special time during the day? • no • yes 
29. If so, at what time of the day? Between and o'clock. 
HEREDITY 
30. Does or did either of your parents often have nose-bleeds? • no Q yes 
Whom?  
31. Does any of your children often have nose-bleeds? • no Q yes 
Whom?  
32. Does any of your brothers or sisters often have nose-bleeds? • no Q yes 
Whom? 
33. Does any of your other close relatives often have nose-bleeds? • no • yes 
Whom?...  
BLEEDING TENDENCY 
34. Are there any inherited blood disease among your relatives? Q no • yes 
What disease?......... In whom?  
35. Do you think that you bruise abnormally easily? • no 
• yes-on the arms 
• yes-on the body 
36. Do you think that you bleed longer than normal from a skin cut? • no • yes 
37. Do you think that you bleed more or longer than normal 
after a tooth extraction? • no • yes 
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DISEASES 
no 
Have you been or 
are you being treated for: 
38. Blood disease? Which? • 
39. Diabetes? • 
40. Liver disease? Which? • 
41. Kidney disease? Which? • 
42. Heart disease? Which? • 
43. Disease of the blood vessels? Which? • 
44. Joint disease? Which? • 
45. Have you had a peptic ulcer? 
When?  
46. Have you had gastric bleeding? 
When?  
47. Has any doctor told you that you are suffering from 
hypertension? 
48. Do you often suffer from headache? 
49. Do you often suffer from rheumatism? 
MEDICINE 
50. Are you being treated continuously with any medicine? 
51. How often do you take medicine for aches and pains? 
( see question 9) 
52. When you take medicine for aches and pains, 
how many tablets do you usually take daily? 
53. Do you generally take medicine for aches and pains 
when having a common cold? 
54. Do you generally take medicine for aches and pains 
during menstruation? 
yes, yes, yes, 
not formerly still on 
treated treated treatment 
• • • 
• ü • 
• • • 
• • • 
• • • 
• • • 
• • • 
Q no 
• yes, not visible on X-ray 
• yes, visible on X-ray 
• yes, operated on 
Q no 
• yes, not operated on 
• yes, operated on 
• no 
• yes, but not treated. 
• yes, formerly treated 
Q yes, still on treatment 
• no Q yes 
• no • yes 
• no • yes 
• never, or occasionally 
• at least once a month 
• at least once a week 
Q at least once a day 
• 1-3 
• 4-5 
• more than 6 
• no Q yes 
Q no • yes 
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DISEASES AND OPERATIONS ON THE NOSE 
55. Do you have any trouble with nasal blockage? 
56. On which side of the nose do you have nasal blockage? 
57. Are you often troubled by mucous secretion 
from the nose? 
58. Do you often have to remove crusts from your nose? 
59. How often do you have colds? 
60. Have you ever had sinusitis? 
61. Have you ever been irrigated for sinusitis? 
62. Do you usually bleed for a long time after the irrigation? 
63. Have you had any operations on your sinuses? 
64. Do you have or have you had hay fever? 
65. Have you had nasal polyps? 
66. Have you been operated on for nasal polyps? 
67. Have you had any other operations on your nose? 
68. If so, when? and for what?  
• no 
• yes, sometimes 
• yes, constantly 
• the right side 
Q the left side 
Q both sides 
• no • yes 
• no • yes 
• less than once a year 
• once a year 
• 2-4/year 
• more than 4/year 
• no 
• yes, once 
• yes, several times 
• no 
• yes, once 
• yes, several times 
• no • yes 
Q no • yes 
• no 
Q yes, several years ago 
Q yes, last couple of years 
• no 
• yes, several years ago 
• yes, last couple of years 
• no 
• yes, several years ago 
• yes, last couple of years 
• no • yes 
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WORK ENVIRONMENT 
69. Are there gases, dirt or dust at your place of work 
that irritate your nose? • no • yes 
70. If so, what kind of substanses?. 
71. Do you usually get nose-bleeds when something 
irritates your nose? • no Qyes 
SMOKING HABITS 
72. Have you smoked regularly during any 
period of your life? • no • yes 
73. Do you smoke at present? • no • yes 
74. When you smoke, do you blow the smoke 
out through your nose? • no • yes 
75. Have you noticed any connection between smoking 
and your nose-bleeds? • no Q yes 
MISCELLANEOUS 
76. Have you noticed that the nose-bleeds occur in 
special situations? If so, what situation?  
77. Does the bleeding generally come from the same side? • no 
• yes, the right side 
Q yes, the left side 
På grund av upphovsrättsliga skäl kan vissa ingående delarbeten ej publiceras här. 
För en fullständig lista av ingående delarbeten, se avhandlingens början.
Due to copyright law limitations, certain papers may not be published here.
For a complete list of papers, see the beginning of the dissertation.
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